Statements (55)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:superhero
|
| gptkbp:activities |
beta-2 adrenergic agonist
|
| gptkbp:appointed_by |
inhalation aerosol
nebulizer solution |
| gptkbp:approves |
gptkb:1981
|
| gptkbp:brand |
gptkb:Ventolin
gptkb:Pro_Air gptkb:Proventil |
| gptkbp:category |
gptkb:C
|
| gptkbp:clinical_trial |
Phase III
|
| gptkbp:contraindication |
severe cardiac disease
hypersensitivity to albuterol |
| gptkbp:dosage_form |
oral tablet
inhalation solution inhalation powder oral syrup |
| gptkbp:duration |
as needed
scheduled use |
| gptkbp:education |
importance of adherence to therapy
recognizing side effects when to seek medical help proper inhaler technique keeping track of symptoms |
| gptkbp:formulation |
gptkb:product
gptkb:tablet metered-dose inhaler solution for nebulization |
| https://www.w3.org/2000/01/rdf-schema#label |
albuterol sulfate
|
| gptkbp:ingredients |
C13 H21 N
|
| gptkbp:interacts_with |
MAO inhibitors
diuretics beta-blockers |
| gptkbp:is_available_on |
generic drug
|
| gptkbp:is_monitored_by |
heart rate
lung function potassium levels |
| gptkbp:is_used_for |
gptkb:asthma
chronic obstructive pulmonary disease |
| gptkbp:manager |
oral
inhalation |
| gptkbp:produced_by |
various pharmaceutical companies
|
| gptkbp:side_effect |
headache
cough dry mouth hypokalemia nervousness tremors palpitations muscle cramps throat irritation tachycardia |
| gptkbp:storage |
room temperature
|
| gptkbp:type_of |
51022-70-9
|
| gptkbp:bfsParent |
gptkb:Combivent_Respimat
|
| gptkbp:bfsLayer |
6
|